Cargando…
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
The SARS-CoV-2 virus, the pathogen causing COVID-19, has caused more than 200 million confirmed cases, resulting in more than 4.5 million deaths worldwide by the end of August, 2021. Upon detection of SARS-CoV-2 infection by pattern recognition receptors (PRRs), multiple signaling cascades are activ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842579/ https://www.ncbi.nlm.nih.gov/pubmed/35176485 http://dx.doi.org/10.1016/j.ymthe.2022.02.014 |
_version_ | 1784651075185278976 |
---|---|
author | Zhang, Shilei Wang, Lulan Cheng, Genhong |
author_facet | Zhang, Shilei Wang, Lulan Cheng, Genhong |
author_sort | Zhang, Shilei |
collection | PubMed |
description | The SARS-CoV-2 virus, the pathogen causing COVID-19, has caused more than 200 million confirmed cases, resulting in more than 4.5 million deaths worldwide by the end of August, 2021. Upon detection of SARS-CoV-2 infection by pattern recognition receptors (PRRs), multiple signaling cascades are activated, which ultimately leads to innate immune response such as induction of type I and III interferons, as well as other antiviral genes that together restrict viral spread by suppressing different steps of the viral life cycle. Our understanding of the contribution of the innate immune system in recognizing and subsequently initiating a host response to an invasion of SARS-CoV-2 has been rapidly expanding from 2020. Simultaneously, SARS-CoV-2 has evolved multiple immune evasion strategies to escape from host immune surveillance for successful replication. In this review, we will address the current knowledge of innate immunity in the context of SARS-CoV-2 infection and highlight recent advances in the understanding of the mechanisms by which SARS-CoV-2 evades a host's innate defense system. |
format | Online Article Text |
id | pubmed-8842579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-88425792022-02-15 The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies Zhang, Shilei Wang, Lulan Cheng, Genhong Mol Ther Review The SARS-CoV-2 virus, the pathogen causing COVID-19, has caused more than 200 million confirmed cases, resulting in more than 4.5 million deaths worldwide by the end of August, 2021. Upon detection of SARS-CoV-2 infection by pattern recognition receptors (PRRs), multiple signaling cascades are activated, which ultimately leads to innate immune response such as induction of type I and III interferons, as well as other antiviral genes that together restrict viral spread by suppressing different steps of the viral life cycle. Our understanding of the contribution of the innate immune system in recognizing and subsequently initiating a host response to an invasion of SARS-CoV-2 has been rapidly expanding from 2020. Simultaneously, SARS-CoV-2 has evolved multiple immune evasion strategies to escape from host immune surveillance for successful replication. In this review, we will address the current knowledge of innate immunity in the context of SARS-CoV-2 infection and highlight recent advances in the understanding of the mechanisms by which SARS-CoV-2 evades a host's innate defense system. American Society of Gene & Cell Therapy 2022-05-04 2022-02-14 /pmc/articles/PMC8842579/ /pubmed/35176485 http://dx.doi.org/10.1016/j.ymthe.2022.02.014 Text en © 2022 The American Society of Gene and Cell Therapy. |
spellingShingle | Review Zhang, Shilei Wang, Lulan Cheng, Genhong The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies |
title | The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies |
title_full | The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies |
title_fullStr | The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies |
title_full_unstemmed | The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies |
title_short | The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies |
title_sort | battle between host and sars-cov-2: innate immunity and viral evasion strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842579/ https://www.ncbi.nlm.nih.gov/pubmed/35176485 http://dx.doi.org/10.1016/j.ymthe.2022.02.014 |
work_keys_str_mv | AT zhangshilei thebattlebetweenhostandsarscov2innateimmunityandviralevasionstrategies AT wanglulan thebattlebetweenhostandsarscov2innateimmunityandviralevasionstrategies AT chenggenhong thebattlebetweenhostandsarscov2innateimmunityandviralevasionstrategies AT zhangshilei battlebetweenhostandsarscov2innateimmunityandviralevasionstrategies AT wanglulan battlebetweenhostandsarscov2innateimmunityandviralevasionstrategies AT chenggenhong battlebetweenhostandsarscov2innateimmunityandviralevasionstrategies |